The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
Blackstone Inc. BX
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Blackstone Inc.
read at $130.00
Blackstone Inc. holds its Markup at $130.00.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 2 days |
| Price | $130.00 |
| Valuation | 29.08 trailing · 17.47 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.58 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $125.82 fair value estimate, strong competitive moat, 5.70% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 5.70% |
| Profit margin | 21.21% |
| Debt to equity | 72.02 |
| Analyst consensus | Buy · 21 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity: Financials sector Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Alternatives giant fails ethical screen outright
Picture the firm that channels billions into private equity and real estate for the world's largest investors. Blackstone looks impressive on paper with its strong moat, 30% ROE and steady 6% revenue growth. We pass anyway because the business activity screen flags it outright.
Forward earnings sit at 17 times with 21% profit margins and analysts clustered around a buy rating. The numbers show a capable operator in alternatives, yet the valuation already sits above our fair value with little margin left. Scale alone does not override the ethical verdict.
The real risk is the screen failure itself, which points to exposures we do not accept regardless of moat strength. Cyclical flows in private markets can amplify that issue quickly. Analysis, not advice.
| Forward P/E | 17.5x expensive even after accounting for its growth |
| Trailing P/E | 29.1x a premium valuation |
| Revenue growth | 5.7% slow but positive growth |
| Profit margin | 21.2% healthy profit margins |
| Return on equity | 29.5% an exceptional return on shareholder capital |
| Debt to equity | 0.72 moderate, manageable leverage |
| Current ratio | 0.90 below 1 — short-term bills exceed liquid assets |
| Beta | 1.58 much more volatile than the market |
| Market cap | $161.8B |
| Employees | 5,285 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on BX
- › Inside Project Peregrine: Why Blackstone and KKR Bought Into Kuwait’s Oil Pipelines Insider Monkey · 22h ago
- › 3 Large-Cap Stocks Worth Investigating StockStory · 23h ago
- › HSBC to sell Australian loan book to Blackstone Retail Banker International · 1d ago
- › Jersey Mike’s Stock Slides Below IPO Price in Market Debut Barrons.com · 2d ago
- › Sector Update: Financial Stocks Advance Thursday Afternoon MT Newswires · 2d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in BX's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
BX trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 10.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 14%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (20 analysts) rates it buy, with a mean price target of $144. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-11 | PORAT RUTH M | Director | 438 | $53,974 | |
| 2026-05-01 | SAWHNEY VIKRANT | Officer | 30,014 | $3,775,565 | |
| 2026-04-01 | PORAT RUTH M | Director | 1,961 | · | |
| 2026-04-01 | SAWHNEY VIKRANT | Officer | 129,077 | · | |
| 2026-04-01 | FINLEY JOHN G | Officer | 152,222 | · | |
| 2026-04-01 | BARATTA JOSEPH P | Director | 124,626 | · | |
| 2026-04-01 | BREYER JAMES W | Director | 1,961 | · | |
| 2026-04-01 | CHAE MICHAEL S. | Chief Financial Officer | 152,667 | · | |
| 2026-04-01 | GRAY JONATHAN D. | President | 302,662 | · | |
| 2026-04-01 | PARRETT WILLIAM G | Director | 2,048 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Sale | 15K–50K |
| 15 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 1 May2026 | Ro Khanna | Democrat | sell | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $121.40 | -2.2% | · | $978 | -2.2% |
| 2 months | $113.78 | +4.3% | $1.16 | $1,053 | +5.3% |
| 3 months | $101.18 | +17.3% | $1.16 | $1,184 | +18.4% |
| 6 months | $150.94 | -21.4% | $2.65 | $804 | -19.6% |
| 1 year | $137.95 | -14.0% | $4.97 | $896 | -10.4% |
| 2 years | $112.49 | +5.5% | $9.02 | $1,135 | +13.5% |
| 3 years | $80.37 | +47.7% | $12.38 | $1,631 | +63.1% |
| 5 years | $80.45 | +47.5% | $20.84 | $1,734 | +73.4% |
Historical returns from market close data. Past performance does not guarantee future results.